SThree plc
09 December 2005
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE
UNITED STATES, CANADA, AUSTRALIA OR JAPAN
9 December 2005
STHREE plc
Over-allotment shares
Further to the announcement dated 11 November 2005 in relation to the offering
of ordinary shares of 1 p each in SThree plc ('SThree'), SThree is pleased to
announce that UBS has:
- sold 2,242,905 over-allotment shares on behalf of Simon Arber; and
- sold 2,242,904 over-allotment shares on behalf of Bill Bottriell
The total number of over-allotment shares comprised in the over-allotment
arrangements was therefore 4,485,809 taking the total number of ordinary shares
subject to the offering to 44,204,541
UBS (the stabilisation manager) announces that the stabilisation period has now
ended. UBS confirms that the following transactions were effected during the
stabilisation period:
Trade Date Highest Price Paid Lowest Price Paid
14 November 200 200
15 November 200 200
16 November 200 198
17 November 198 198
23 November 196 196
Stabilisation Period -
Commencement: 11 November 2005
End (last transaction): 7 December 2005
- ENDS -
This document has been issued by SThree and is the sole responsibility of
SThree.
UBS Limited ('UBS') is acting exclusively for SThree in relation to the Global
Offer and no one else and will not be responsible to anyone other than SThree
for providing the protections afforded to clients of UBS Limited nor for
providing any advice in relation to the Global Offer, the contents of this
announcement or any other matter referred to herein.
Investec Bank (UK) Limited and Oriel Securities Limited, each of which is
authorised and regulated in the United Kingdom by the Financial Services
Authority, are advising SThree in relation to the Global Offer and no one else
and will not be responsible to anyone other than SThree for providing the
protections afforded to the customers of Investec Bank (UK) Limited and Oriel
Securities Limited nor for providing any advice in relation to the Global Offer
or any other matter referred to herein
The information contained herein does not constitute an offer to sell or the
solicitation of an offer to buy nor shall there by any sale of the securities
referred to herein in any jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration, exemption of registration or
qualification under the securities laws of any such jurisdiction.
The price and value of the securities referred to herein may go up as well as
down. Persons needing advice should consult a professional adviser.
These materials are not for distribution, directly or indirectly, in or into the
United States, Australia, Canada or Japan. This document does not constitute an
offer of securities for sale in the United States, nor may the securities be
offered or sold in the United States absent registration or an exemption from
registration as provided in the US Securities Act of 1933, and the rules and
regulations thereunder. No securities are being registered for offer or sale in
the United States and no public offering of the securities in the United States
will be made.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.